Insiders Kabra Drugs Limited

Equities

524322

INE323K01017

Market Closed - Bombay S.E. Other stock markets 06:00:55 2024-06-24 EDT			5-day change	1st Jan Change
7.91 ^INR	0.00%		0.00%	+46.75%

05-30	Kabra Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-14	Kabra Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kabra Drugs Limited Announces Resignation of Muralidharan R as Director	22-11-02	CI
Kabra Drugs Limited Announces Board Appointments	22-09-30	CI
Kabra Drugs Limited Announces Executive Changes	22-07-07	CI
Kabra Drugs Limited Announces Appointment of K.N Anand as Additional Director (Independent Director)	22-06-09	CI
Kabra Drugs Limited Announces Resignation of Churchil Durai M Jebastine as Director	22-05-30	CI
Kabra Drugs Limited Announces Resignation of Pritam Paul as Secretary and Compliance Officer	22-04-18	CI
Kabra Drugs Limited Appoints Pritam Paul as Company Secretary and Compliance Officer	22-03-18	CI
Kabra Drugs Limited Announces the Resignation of Company Secretary and Compliance Officer Radhika Dammani	22-03-03	CI
Kabra Drugs Limited Announces Resignation of Board of Directors	20-09-07	CI
Snehlata Gadiya to Resign from the Position of Director of Kabra Drugs Limited	20-02-12	CI
Kabra Drugs Limited Announces Directorate Changes	20-01-29	CI
Kabra Drugs Limited Announces Resignation of Shyam Kabra from its Board	18-08-24	CI
Kabra Drugs Limited Announces Board Changes	18-08-11	CI
Kabra Drugs Limited Announces Executive Appointments	18-07-10	CI
Kabra Drugs Limited Announces Resignation of Mr. Kuldeep Kumar Ajmera as Independent Director	18-07-02	CI
Kabra Drugs Limited Announces Resignation of Madhusudan Sharma as Independent Director	18-06-22	CI
Kabra Drugs Limited Announces Resignation of Shivaji Singh as Independent Director	18-06-20	CI
Kabra Drugs Limited Announces Resignation of Kusum Kabra, Executive Director	18-05-23	CI
Arvind Poal Resigns as Chief Financial Officer of Kabra Drugs Limited	17-12-04	CI
Kabra Drugs Limited Announces Resignation of Mahendra Singh Madloi as Director	17-10-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Kabra Drugs Limited

Equities

524322

INE323K01017

Insiders

Filters